Olivier Gruselle

Predictive Gene Signature in MAGE-A3 Antigen-Specific Cancer Immunotherapy

Fernando Ulloa‐Montoya, Jamila Louahed, Benjamin Dizier et al. · Journal of Clinical Oncology · 2013 · 475 citations · Full text

Medicine, Immunology, Oncology +17

Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons

Michael G. Ison, Alberto Papi, Eugene Athan et al. · Clinical Infectious Diseases · 2024 · 162 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort study

Koos Korsten, Niels Adriaenssens, Samuel Coenen et al. · European Respiratory Journal · 2020 · 159 citations · Full text

Veterinary Medicine, Geriatric Medicine, Infectious Diseases +15

Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma

Lars Dyrskjøt, Karsten Zieger, Tina Kissow Lildal et al. · British Journal of Cancer · 2012 · 84 citations · Full text

Medicine, Oncology, Urology +16

Association of gene expression signature and clinical efficacy of MAGE-A3 antigen-specific cancer immunotherapeutic (ASCI) as adjuvant therapy in resected stage IB/II non-small cell lung cancer (NSCLC)

Johan Vansteenkiste, M. Zieliński, Issa J Dahabreh et al. · Journal of Clinical Oncology · 2008 · 60 citations

Life Sciences, Immunology, Oncology +17